<p>aRR = adjusted relative risk<br>cat. = category<br>CAT = cancer-associated thrombosis<br>CI = confidence interval<br>CrCl = creatinine clearance<br>CRNM = clinically relevant nonmajor<br>CVC = central venous catheters<br>DVT = deep vein thrombosis<br>ESA = erythropoiesis-stimulating agent<br>GI = gastrointestinal<br>GU = genitourinary<br>HR = hazard ratio<br>IMiD = immunomodulatory drug<br>IR = incidence rate<br>ISTH = International Society on Thrombosis and Haemostasis<br>LMWH = low-molecular-weight heparin<br>NA = not applicable<br>NOAC = non-vitamin K antagonist oral anticoagulant <br>OR = odds ratio<br>PE = pulmonary embolism<br>RR = relative risk<br>RVT = residual vein thrombosis <br>UFH = unfractionated heparin<br>VTE = venous thromboembolism</p>